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Background. Understanding the mechanisms underlying generation of neuronal variability and complexity remains the
central challenge for neuroscience. Structural variation in the neuronal genome is likely to be one important mechanism for
neuronal diversity and brain diseases. Large-scale genomic variations due to loss or gain of whole chromosomes (aneuploidy)
have been described in cells of the normal and diseased human brain, which are generated from neural stem cells during
intrauterine period of life. However, the incidence of aneuploidy in the developing human brain and its impact on the brain
development and function are obscure. Methodology/Principal Findings. To address genomic variation during development
we surveyed aneuploidy/polyploidy in the human fetal tissues by advanced molecular-cytogenetic techniques at the single-cell
level. Here we show that the human developing brain has mosaic nature, being composed of euploid and aneuploid neural
cells. Studying over 600,000 neural cells, we have determined the average aneuploidy frequency as 1.25–1.45% per
chromosome, with the overall percentage of aneuploidy tending to approach 30–35%. Furthermore, we found that mosaic
aneuploidy can be exclusively confined to the brain. Conclusions/Significance. Our data indicates aneuploidization to be an
additional pathological mechanism for neuronal genome diversification. These findings highlight the involvement of
aneuploidy in the human brain development and suggest an unexpected link between developmental chromosomal
instability, intercellural/intertissular genome diversity and human brain diseases.
Citation: Yurov YB, Iourov IY, Vorsanova SG, Liehr T, Kolotii AD, et al (2007) Aneuploidy and Confined Chromosomal Mosaicism in the Developing
Human Brain. PLoS ONE 2(6): e558. doi:10.1371/journal.pone.0000558
INTRODUCTION
The human genome seems to represent a highly dynamic and
relatively instable system at interindividual and intercellular levels.
The variation of chromosome numbers between individual
organisms or cells of an organism is among the main types of
genomic instability [1–4]. The biological consequences of genetic
instability manifested as loss or gain of whole chromosomes
(aneuploidy) usually are devastative and hallmark numerous
pathological conditions in humans. Aneuploidy arisen from
meiotic errors is the leading genetic cause of morbidity and
mortality in humans [5]. A cascade of abnormal mitotic divisions
accompanied by formation of aneuploidy is a consistent finding in
virtually all cancers [6–8]. Moreover, abnormal functioning of
mitotic machinery associated with aneuploidy formation is
suggested to underlie aging [9]. Stochastic (or spontaneous)
chromosomal variations in somatic cells appearing as low-level
mosaic aneuploidy can be registered in all somatic cell popula-
tions. However, usually being considered insignificant, low-level
somatic chromosomal mosaicism is frequently overlooked, prob-
ably, because of unapparent phenotypic effects [4,10].
The genetic complexity of the brain is employed to explain the
fascinating abilities of humans such as speech, consciousness, tool
use, symbolic thought, cultural learning, and self-awareness. This
can be naturally affected by different genetic and environmental
factors during the intrauterine period, leading, thereby, to
individual differences in brain organization and function after
birth [3]. A number of attempts at the assessment of chromosome
variations in the adult human brain have indicated that mosaic
aneuploidy do present in the normal and diseased brain [11–15].
The murine brain, considered as an adequate model of human
brain diseases [16], has been documented to possess aneuploid
developing and adult neurons [17]. Murine aneuploid neurons are
functionally active and may be integrated into the brain circuitry
[18]. However, the nature, magnitude, and significance of
aneuploidy in the developing and adult human brain are a matter
of conjecture. To the best of our knowledge, aneuploidy in the
developing human brain has not been experimentally assessed. To
fill this gap in our knowledge about chromosomal (genomic)
variations during human development, we have performed the
study of aneuploidy in the developing human brain.
RESULTS
Stochastic aneuploidy frequency in the developing
brain
Aneuploidy was surveyed in 12 post-mortem fetal brain samples by
molecular cytogenetic techniques specially elaborated for precise
identification of low-level chromosomal mosaicism at the single-
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ization (mFISH) with quantification of FISH signals (QFISH) [19],
primed in situ labeling (PRINS) and interphase chromosome-
specific Multicolor Banding (MCB) [15]. Interphase mFISH with
arbitrary selected chromosome enumeration DNA probes for six
different autosomes (chromosomes 1, 9, 15, 16, 17, 18) and the sex
chromosomes (X and Y) has shown high hybridization efficiency
(over 99.5%). This was considered to diminish possible misinter-
pretations of aneuploidy scoring (Figure 1, A to C). Analysis of
more than 420,000 cells from twelve samples of the fetal brain and
85,000 chorionic villi cells was performed by interphase mFISH
(Table 1). No fewer than 5000 nuclei from each brain tissue and
no fewer than 1000 nuclei from chorionic villi sample were scored
per chromosome. Loss of the Y chromosome was detected in 0.2%
of brain cells in male fetuses, while no evidences for loss of
chromosome X and simultaneously both autosomes have been
obtained. One FISH signal per interphase nucleus for autosomal
DNA probes was detected in 6–12% of nuclei scored in different
brain tissue samples. Since quantification of FISH signals have
been applied, it was possible to differ between true hypodiploid
(monosomic) and euploid cells featured by associated FISH signals
(a signal appearance similar to monosomy). We have determined
1.03% of the brain cells and 0.51% of chorionic cells to be true
monosomic, while the most part of cells with one signal showed
associated signals suggesting two homologous chromosomes in
a cell (Table 1). The frequency of cells with chromosome losses in
the brain was found to increase significantly versus chorionic
tissues (p,0.001). The frequency of hyperdiploid cells with
chromosome gains including autosomal trisomy, trisomy of the
X chromosome (female fetuses), disomy of the X chromosome
(male fetuses), and tetrasomy in the fetal brain was similar to that
in chorionic tissue (0.42 and 0.46%, respectively, p=0.08).
Polyploidy (tetraploidy) was detected in 0.04% of fetal brain cells
and in 0.06% of chorionic cells (p=0.026). Multiple numerical
chromosome imbalances involving more than one chromosome
pair in one cell (i.e. simultaneous losses or gains of several non-
homologous chromosomes) were not registered at all. Simulta-
neous gain of the chromosome X and chromosome Y was detected
in 0.02% of cells in one brain sample only. We have observed
significant difference in the frequency of aneuploidy (losses + gains)
between the brain and chorionic villi (1.45 and 0.98, respectively,
p,0.001; Table 1). The mean stochastic (or background)
aneuploidy rate involving individual chromosomes (M), standard
deviation (SD), the threshold levels (M+3SD) for chromosome
losses and gains were calculated (Table 2). Stochastic chromosome
losses and gains (the rates calculated without outliers) in fetal brain
cells were registered with the mean frequency 0.91% (SD 0.37)
and 0.34% (SD 0.19) per individual chromosome pair, re-
spectively. Cut-of levels (M+3SD) were determined as 0.44–
3.38% for losses and 0.40–2.68% for gains affecting different
chromosomes (Table 2).
Figure 1. Molecular cytogenetic analysis of aneuploidy in the fetal
human brain. (A to C). Interphase FISH with chromosome-enumeration
DNA probes: (A) two nuclei characterized by additional chromosomes Y
and X and a normal nucleus; (B) a nucleus with monosomy of
chromosome 15 and a normal nucleus; (C) a nucleus with monosomy of
chromosome 18 and a normal nucleus. (D to G) interphase
chromosome-specific MCB: nuclei with monosomy, disomy, trisomy
and G-banding ideograms with MCB color-code labeling of a chromo-
some (from left to right), (D) - chromosome 9, (E) - chromosome 16, and
(F) - chromosome 18. (G) interphase QFISH: (1) a nucleus with two
signals for chromosomes 18 (relative intensities: 2058 and 1772 pixels),
(2) a nucleus with one paired signal mimics monosomy of chromosome
18 (relative intensity: 4012 pixels), (3) a nucleus with two signals for
chromosomes 15 (relative intensities: 1562 and 1622 pixels), (4)
a nucleus with one signal showing monosomy of chromosome 15
(relative intensity: 1678 pixels).
doi:10.1371/journal.pone.0000558.g001
Table 1. Comparison of aneuploidy frequency in the fetal brain cells and chorionic villi cells detected by interphase mFISH analysis
(12 fetuses analyzed).
..................................................................................................................................................
Tissue Number of cells scored Normal diploid cells Aneuploid Cells (loss) Aneuploid cells (gain) Aneuploid cells (loss+gain) Polyploid cells
Brain 424674 418356 (98.5%) 4361 (1.03%) 1774 (0.42%) 6135 (1.45%) 183 (0.04%)
Chorion 85123 84241 (98.97%) 438 (0.51%) 392 (0.46%) 830 (0.97%) 52 (0.06%)
P-values P,0.001 P=0.08 P,0.001 P=0.026
Eight arbitrary selected chromosomes (chromosomes 1, 9, 15, 16, 17, 18, X and Y) were analyzed for each fetus. No less than 5000 cells were scored for each
chromosome for the brain tissue and 1000 cells for chorionic tissue.
doi:10.1371/journal.pone.0000558.t001
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brain
Four fetal brain samples were characterized by chromosome-
specific aneuploidy inasmuch as the rate of aneuploidy involving
single chromosome pair in these samples was significantly higher
than the cut-off level (Figure 2, Table 2). The chromosomal
mosaicism confined to the fetal brain was referred to aneuploidy
manifested as (i) chromosome X gain (2.8% versus 1.2% of cells in
chorion; p=0.004) and chromosome Y gain (5.9% versus 1.8% of
cells in chorion; p,0.001), (ii) chromosome X loss (5.4% versus
1.1% of cells in chorion; p,0.001), (iii) chromosome 15 loss (6.2%
versus 1.2% of cells in chorion; p,0.001); (iv) chromosome 18 loss
(6.5% versus 3.2% of cells in chorion; p,0.001). These outliers
were detected in the fetal brain only and were observed neither in
chorionic cells nor in skin fibroblasts of the same fetuses as was
Table 2. Stochastic aneuploidy frequency (%) involving chromosome loss and gain and the average chromosome instability index
(losses and gains summed per individual chromosome pair) in the human fetal brain
..................................................................................................................................................
Chromosome; Number of scored cells (n) Mean (SD) without outliers Threshold level (M+3SD) Min(Outliers), Max (Outliers) Mean with outliers (SD)
Chromosome 1 loss and gain; n=60745 1.04 (0.44) and 0.28 (0.11) 2.36 and 0.61 0.3; 1.7 and 0.1; 0.4
Chromosome 9 loss and gain; n=60922 0.69 (0.46) and 0.20 (0.14) 2.07 and 0.62 0.2; 1.6 and 0.1; 0.6
Chromosome 15 loss and gain; n=60554 0.97 (0.56) and 0.20 (0.10) 2.65 and 0.40 0.3; 2,2 (6.2) and 0.1; 0.4 1.41 (1.60)
Chromosome 16 loss and gain; n=60714 1.08 (0.57) and 0.23 (0.13) 2.79 and 0.62 0.3; 2.0 and 0.1; 0.4
Chromosome 17 loss and gain; n=60558 0.75 (0.35) and 0.18 (0.10) 1.8 and 0.48 0.3; 1.3 and 0.1; 0,4
Chromosome 18 loss and gain; n=60791 0.92 (0.64 and 0.33 (0.16) 2.84and 0.81 0.3; 2.2(6.5) and 0.1; 0.5 1.39 (1.72)
Chromosome X loss and gain; n=26436
(female fetuses); n=33954 (males fetuses)
1.60 (0.59) and 0.73 (0.65) 3.37 and 2.68 0.8; 2.2 (5.4) and 0.0; 2.0 2.36 (1.77) 0.90 (0.84)
Chromosome Y loss and gain; n=33954 0.20 (0.08) and 0.58 (0.70) 0.44 and 2.68 0.0; 0.3 and 0.1; 2.0 (5.8) 1.32 (2.07)
Mean (SD), loss and gain; n=424674 0.91 (0.37) and 0.34 (0.19) 1.03 (0.59) and 0.42 (0.38)
Average Chromosomal Instability Index;
(Loss+Gain); n=424674
1.25 1.45
doi:10.1371/journal.pone.0000558.t002
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Figure 2. The frequency of chromosome losses and gains in the fetal human tissues exhibiting chromosomal mosaicism confined to the fetal
brain. Aneuploidy frequency involving chromosomes 1, 9, 15, 16, 17, 18, X and Y was determined by interphase mFISH, MCB and PRINS techniques.
(A) demonstration of selective chromosome X and chromosome Y gains, (B) demonstration of selective chromosome 15 loss, (C) demonstration of
selective chromosome X loss, and (D) demonstration of selective chromosome 18 loss.
doi:10.1371/journal.pone.0000558.g002
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G, and Fig. 2). Only one fetus had low-level chromosome specific
mosaicism confined to the chorionic villi, i.e. trisomy of
chromosome 18 in 2.3% (cut-off level is 0.8%), while only 0.4%
of fetal brain cells had trisomy 18 (p,0.001). The application of
PRINS and MCB for evaluation of random fluctuation of
aneuploidy rate (chromosomes 1, 9, 15, 16, 18, X and Y) scoring
more than 180,000 cells has confirmed the results obtained by
interphase mFISH (Figure 1, D to F). Average chromosome
instability quantitative index was calculated as 1.25 (without
outliers) and 1.45 (with outliers) in the fetal brain (Table 2). Since
molecular cytogenetic studies using DNA probes for randomly
selected arbitrary chromosomes have exhibited similar pattern of
involvement in autosomal aneuploidy and multiple aneuploidy has
not been detected, we assumed that extrapolating the data towards
the entire chromosome set (or entire genome) would not be
exceedingly speculative. Cumulative frequency of stochastic
aneuploidy or the overall percentage of aneuploid cells in the
developing brain, calculated for 22 pairs of autosomes and two sex
chromosomes, is, therefore, 30% (without outliers). Taking into
account the existence of chromosome-specific brain-confined
mosaic aneuploidy, the overall percentage of aneuploid cells in
the developing human brain tends to approach 35%. Average
chromosome instability quantitative index in chorionic tissues and
fetal skin was estimated as 0.98% and 0.82% corresponding to the
overall aneuploidy frequency of 24% and 19%, respectively.
Studying over 600.000 individual neural cells, we have concluded
that the developing human brain exhibits increased level of
stochastic aneuploidy and is frequently affected by chromosome-
specific mosaicism confined to the brain. Therefore, the de-
veloping human brain has mosaic nature as both euploid (,70%)
and aneuploid (,30%) neural cells are present.
DISCUSSION
Somatic mosaicism makes an important contribution to genetic
and phenotypic variation among humans. Somatic chromosomal
mosaicism producing intercellular genomic variations simulta-
neously involving from hundreds to thousands genes possesses the
potential to produce the most dramatic changes of cellular
physiology and behavior [10]. Interphase FISH technique is
known as a powerful approach to assess intercellular chromosome
variations at the single cell level [3,4]. However, FISH is affected
by potential artefactual problems that might interfere with analysis
of chromosome gain and loss in a cell. To avoid considering FISH
artifacts as false-positive chromosome losses or gains, we have
introduced two independent approaches: QFISH and interphase
chromosome-specific MCB, allowing accurate definition of the
normal thresholds of aneuploidy in human somatic cells [15,19].
The first documented tissue-specific chromosomal mosaicism in
normal human pregnancies was confined placental mosaicism
exclusively expressed in extraembryonic tissues, which is not
considered a chromosomal abnormality directly affecting fetus
[20]. The developing human brain is, probably, the first embryonic
tissue demonstrating confined chromosomal mosaicism. The
chromosomal mosaicism confined exclusively to embryonic somatic
tissue has the potential to possess primary effect on the intrauterine
development. Therefore, chromosomal mosaicism confined to the
fetal brain can be considered a possible cause of alterations in
prenatal brain development, leading to fetal loss or abnormal brain
functioning after birth.
Most postmitotic cells populating the brain are formed from
neuronal and glial precursor cells originated from the embryonic
neural stem cells. Chromosomal segregation defects during mitosis
can occur in rapidly proliferating stem cells and, thereafter, in
neuronal/glial progenitor cells with limited self-renewal ability.
Aneuploid proliferating progenitor cells can be precursors of
aneuploid neurons and glial cells. Previous studies indicate that the
mean rate of aneuploidy per chromosome pair is, probably,
ranged between 0.1 and 0.7% with the overall frequency of
aneuploidy approaching 10% in the adult human brain [14,15]
and is exactly three times less than during the early brain
development. Coincidental with early developmental processes of
proliferation, migration and differentiation, 20–50% of fetal brain
cells normally undergo programmed cell death (PCD) [21].
Ontogenetic decrease of aneuploidy rate indicates that the
clearance of aneuploid cells in the developing brain could be
one of the main functions of PCD. This agrees with the
speculation assuming PCD as a mechanism for neural cell
quantity and, probably, quality control during the development
of the CNS. The data obtained suggest a new role of PCD in the
developing human CNS that could be the protection of the brain
against devastating consequences of developmental genomic
instability. It was hypothesized that genetic and epigenetic
alterations in the apoptotic machinery may result to failed
clearance of abnormal neuronal and glial cells leading, thereby,
to the persistence of aneuploid cells throughout ontogeny [4].
Furthermore, increased developing chromosome instability affect-
ing neuronal and glial cells could be a possible factor predisposing
to brain tumors, which are highly incident among children.
Although these inferences may appear speculative, the link
between PCD, developmental chromosomal instability (aneuploi-
dy) and normal/abnormal CNS development seems to exist.
Most part of neurons and glial cells in the adult human brain
are generated during intrauterine period of life. The adult human
brain consists of 95–100 billions of neurons and as much as one
trillion of glial cells [22]. A typical human mature neuron has
approximately 5,000–200,000 synapses [3]. Aneuploid neurons
are functionally active and may be integrated into the brain
circuitry [18]. As aneuploidization is a pathogenic mechanism that
alters gene expression, the presence of chromosomally abnormal
neurons in the neuronal network should negatively affects neuron-
neuron or neuron-glia interaction and, therefore, the normal
functioning of the brain. Therefore, chromosome variations in the
developing human brain should be ultimately involved in the
pathogenesis of common mental disorders. This speculation is in
accordance with the experimental data suggesting that Alzheimer’s
disease, schizophrenia and autism are likely to associate with
increased level of aneuploidy and polyploidy in different tissues,
including, probably, the brain [11,12,23]. In conclusion, mosaic
aneuploidy affecting the developing brain represents a specific type
of intercellular genomic variations contributing to the generation of
the neuronal diversity and to genetic diseases of the brain [3,4,24].
MATERIALS AND METHODS
Sample Preparations
Post-mortem brain tissue of 12 human fetuses (gestational age 8–
11 weeks) were provided by the Brain and Tissues bank of Medical
University of Rostov-on-Don, Russia. The Ethical Committees of
Institutions involved approved all interventions, and tissue was
collected with proper consent. The written consents of mothers of
the fetuses were obtained. The study using human fetal tissues
performed according to the ethical guidelines of medical research
that are in accordance with Russian Federation laws and the rules
for manipulation with human embryonic and fetal neuronal tissues
accepted by European Commission [25]. Ultrasonic and neuro-
pathological examination found no evidences of disease or
developmental abnormalities. A cytogenetic study of chorionic
Aneuploidy in the Human Brain
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telencephalic regions of the fetal brains were subjected to analysis.
Additionally, autopsy tissues of chorionic villi and fetal skin of
these specimens were selected for molecular cytogenetic studies.
The tissue were collected and stored at 270uC. The processing of
the fetal brain tissue for molecular cytogenetic analysis is described
in detail elsewhere [26]. Shortly, the samples were processed
through disaggregating by homogenizer, treatment with acetic
acid solution (45–60% w/v), and fixation with methanol/acetic
acid mixture (3:1). The suspensions obtained were dropped onto
wet slides similarly to the preparation of metaphase chromosome
spreads. The slides were then dried overnight at room tempera-
ture, dehydrated through ethanol series and processed for FISH.
Multiprobe Fluorescence in Situ Hybridization
(mFISH)
Interphase multiprobe fluorescence in situ hybridization (mFISH)
assay using chromosome enumeration DNA probes was used
[12,14]. Chromosome 1 (D1Z1)-, 9 (D9Z1)-, 15 (D15Z1)-, 16
(D16Z3)-, 17(D17Z1)-, 18 (D18Z1)-, X (DXZ1)-, and Y (DYZ3)-
specific probes labeled either by FluorX (green), Cy3 (red), or
diethylaminocoumarine (blue) were used for multiprobe FISH as
described in details earlier (14). The following probe combinations
have been used: (1+X+Y), (1+9+16), (1+15+17), (1+9+18). Epifluor-
escence microscopy analysis was performed using a Leitz Orthoplan
microscope (Leica Mikroskopie und Systeme, Leitz-Wetzlar; Wet-
zlar, Germany) as well as filter sets for 4,6-diamidino-2-phenylindole
(DAPI), fluorescein isothiocyanate, Spectrum Orange or Cy3. For
each tissue sample and each chromosome enumeration probe no
fewer than 5000 interphase nuclei were scored.
Quantitative FISH technique (qFISH)
Since the specifity of chromosome positioning in interphase nuclei
do not allow the precise identification of chromosome loss due to
FISH signal associations, the fraction of nuclei demonstrating one
hybridization signal was analyzed additionally by a quantitative
FISH technique [15] to discriminate single paired signals from
true single signal (true monosomy). Each interphase nuclei
showing one hybridization signal was captured for quantification
of the signal intensity. The numerical values of the signal relative
intensity in the nuclei with one (true monosomy and two associ-
ated signals) and two separate signals (disomy) were compared.
The relative intensity of FISH signals was obtained by digital
capturing of microscopic image by CCD camera (Cohu, 4910
series, Cohu Inc., San Diego, CA), LG-3 grayscale scientific PCI
frame grabber (Scion Corp., NIH, Frederick, MD), and measuring
signal intensity by Scion Image Beta 4.0.2 (Scion Corporation,
National Institute of Health, Frederick, MD) acquired from www.
scioncorp.com (accessed 12/07/2001). The quantification of FISH
signals from each digital image was processed by the macros
supplied by the manufacturer.
Primed in Situ Labeling (PRINS)
An alternative molecular cytogenetic techniques allowing aneu-
ploidy estimation-primed in situ labeling (PRINS) for chromo-
somes 1, 9, 15, 16, 18, X and Y was applied to analyze the
phenomenon of confined chromosomal mosaicism revealed by
mFISH. The PRINS labeling was performed by using chromo-
some-specific primers for the centromeric alpha-satellite DNA
motifs of aforementioned chromosomes. PRINS protocol and
primers used were described in details earlier [27].
Multicolor Banding (MCB)
Finally, to achieve the highest resolution in aneuploidy scoring,
a multicolor banding (MCB) assay generated on the interphase
nuclei [28], shown to be among the most efficient cytogenetic
approach for studying chromosomes in the human brain [12], was
applied. High resolution multicolour-banding (MCB) patterns
were generated with human microdissection-derived probe-sets
specific for chromosomes 1, 9, 15,16, 18, X and Y. MCB is a three
to five color FISH approach producing a reproducible fluoro-
chrome profile along the chromosomal axis of interphase and
metaphase chromosomes. The methodology was described ealier
by Dr. Thomas Liehr and coworkers [28]. Epifluorescence
microscopy analysis was performed using an Axioplan II
microscope (Zeiss, Jena, Germany) equipped with a CCD camera
(Sony), an HBO 100 mercury lamp, as well as filter sets for 4,6-
diamidino-2-phenylindole (DAPI), diethylaminocoumarine
(DEAC), fluorescein isothiocyanate, Spectrum Orange, Texas
Red, and Cy5. Images were captured and analyzed using the ISIS
digital imaging system (MetaSystems, Altlussheim, Germany).
Data Analysis
No fewer than 5000 nuclei were scored per chromosome and per
sample in multiprobe FISH and PRINS studies and no fewer than
3000 nuclei were assessed per sample per chromosome for
interphase chromosome-specific MCB assay for the brain tissue
samples, and 1000 nuclei for fetal skin and chorionic villi cells. The
mean frequencies of aneuploidy (M), standard deviations (SD),
thresholds levels for gains and losses for outliers of the respective
chromosomes (M+3SD), and statistical significance were de-
termined. The chromosome instability quantitative index (the
fraction of cells with abnormal chromosome number accounted
per individual chromosome pair) was calculated according to
Lengauer and associates [29].
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